RGEN
RGEN
NASDAQ · Life Sciences Tools & Services

Repligen Corp

$123.46
-2.97 (-2.35%)
As of May 9, 1:12 AM ET ·
Day Range $121.26 — $126.83
52W Range $109.50 — $175.77

Performance

1D
1W
1M
3M -14.01%
6M -15.24%
1Y +0.18%
YTD -24.88%
Open$125.83
Previous Close$126.43
Day High$126.83
Day Low$121.26
52W High$175.77
52W Low$109.50
Volume
Avg Volume1.23M
Market Cap7.03B
P/E Ratio143.75
EPS$0.86
SectorLife Sciences Tools & Services

Technical Indicators

Full analysis →
SMA 50 $157.63 Below
SMA 200 $139.06 Below
RSI (14) 28 Oversold
Trend Golden Cross Bullish

Analyst Ratings

Strong Buy
28 analysts
23 Buy 5 Hold 0 Sell
Price Target -49.7% upside
Current
$123.46
Target
$62.10
$40.44 $62.10 avg $74.58

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 743.05M 763.67M 4.59B
Net Income 49.21M 45.52M 325.04M
Profit Margin 6.6% 6.3% 7.1%
EBITDA 137.61M 134.36M 499.02M
Free Cash Flow 285.62M
Rev Growth -2.7% -2.7% +1.3%
Debt/Equity 0.26 0.26 0.50

Life Sciences Tools & Services Peers

Symbol Name Price Change P/E Mkt Cap
TMO Thermo Fisher Scientific Inc $465.00 -1.99% 25.5 174.69B
DHR Danaher Corp $171.16 -2.56% 33.6 124.08B
A Agilent Technologies Inc $115.62 -2.55% 25.5 32.88B
IQV Iqvia Holdings Inc $178.71 +0.04% 20.3 27.54B
MTD Mettler-Toledo International $1,124.46 -14.77% 26.7 23.24B
WAT Waters Corp $355.13 +1.32% 53.5 34.38B

RGEN News

No news for RGEN yet

Quick Stats

Market Cap7.03B
P/E Ratio143.75
EPS$0.86
Volume
SectorLife Sciences Tools & Services